Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction
Shah,K.B. ; Kop,W.J. ; Christenson,R.H. ; Diercks,D.B. ; Henderson,S. ; Hanson,K. ; Li,S.Y. ; Defilippi,C.R.
Shah,K.B.
Kop,W.J.
Christenson,R.H.
Diercks,D.B.
Henderson,S.
Hanson,K.
Li,S.Y.
Defilippi,C.R.
Abstract
Description
Date
2011
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue
Keywords
SDG 3 - Good Health and Well-being
Citation
Shah, K B, Kop, W J, Christenson, R H, Diercks, D B, Henderson, S, Hanson, K, Li, S Y & Defilippi, C R 2011, 'Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction', Clinical Chemistry, vol. 57, no. 6, pp. 874-882. https://doi.org/10.1373/clinchem.2010.159277
